CONSUN PHARMAC.GR.HD -10 Tangible Net Worth Ratio
CONSUN PHARMAC.GR.HD -10 tangible net worth ratio. CONSUN PHARMAC.GR.HD -10 (C1P) has a Tangible Net Worth Ratio of 92.3% as of December 2025. This metric is calculated by deducting intangible assets (€373.62 Million) from net assets (€4.84 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See CONSUN PHARMAC.GR.HD -10 net asset quality index to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of CONSUN PHARMAC.GR.HD -10 (2021–2025)
Tangible net worth ratio of CONSUN PHARMAC.GR.HD -10 from 2021 to 2025. This chart shows how CONSUN PHARMAC.GR.HD -10's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 92.3%, reflecting net assets of €4.84 Billion with intangible assets of €373.62 Million EUR. See C1P working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CONSUN PHARMAC.GR.HD -10 Tangible Net Worth Ratio by Year (2021–2025)
CONSUN PHARMAC.GR.HD -10 tangible net worth ratio by year from 2021 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for CONSUN PHARMAC.GR.HD -10 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see CONSUN PHARMAC.GR.HD -10 market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.3% | €4.84 Billion | €373.62 Million | €6.41 Billion | ▲ +0.9 pp |
| 2024 | 91.3% | €4.39 Billion | €380.10 Million | €5.85 Billion | ▲ +1.5 pp |
| 2023 | 89.9% | €3.92 Billion | €397.42 Million | €5.51 Billion | ▲ +2.3 pp |
| 2022 | 87.5% | €3.44 Billion | €429.31 Million | €4.89 Billion | ▲ +3.4 pp |
| 2021 | 84.1% | €2.91 Billion | €462.21 Million | €4.36 Billion | — |